CDXS - Codexis proposes public offering

Codexis (CDXS) announces an underwritten public offering of shares of its common stock.Underwriters' option to purchase up to an additional 15% shares.Size and terms yet to be finalisedNet proceeds to be deployed for accelerating development of its performance enzyme products and novel biotherapeutic product candidates as well as any additional products or product candidates that Codexis may develop in the future, and for general corporate purposes, including increasing its working capital and capital expenditures.Company may also use a portion of the net proceeds to make investments in, or acquire, complementary businesses, products, services or technologies.

For further details see:

Codexis proposes public offering